T
TMO icon

TOBAM’s Thermo Fisher Scientific TMO Stock Holding History

TOBAM’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-559
Closed -$275K – 286
2026
Q1 		$275K Buy
+559
New +$303K 0.07% 174
2025
Q1 		– Sell
-416
Closed -$216K – 328
2024
Q4 		$216K Sell
416
-121
-23% -$66.5K 0.07% 153
2024
Q3 		$332K Sell
537
-63
-11% -$37.3K 0.06% 152
2024
Q2 		$332K Sell
600
-779
-56% -$446K 0.05% 138
2024
Q1 		$801K Sell
1,379
-54
-4% -$30.3K 0.07% 112
2023
Q4 		$761K Sell
1,433
-452
-24% -$219K 0.07% 100
2023
Q3 		$954K Sell
1,885
-174
-8% -$92.7K 0.08% 99
2023
Q2 		$1.07M Buy
2,059
+64
+3% +$34.5K 0.08% 102
2023
Q1 		$1.15M Buy
1,995
+59
+3% +$33.3K 0.08% 104
2022
Q4 		$1.07M Sell
1,936
-85
-4% -$45K 0.07% 105
2022
Q3 		$1.02M Hold
2,021
– – 0.07% 115
2022
Q2 		$1.1M Buy
2,021
+119
+6% +$65.5K 0.07% 127
2022
Q1 		$1.12M Buy
1,902
+684
+56% +$393K 0.06% 135
2021
Q4 		$813K Sell
1,218
-60
-5% -$37.5K 0.04% 123
2021
Q3 		$730K Sell
1,278
-69
-5% -$37.9K 0.03% 127
2021
Q2 		$680K Hold
1,347
– – 0.03% 136
2021
Q1 		$615K Sell
1,347
-82
-6% -$39.1K 0.03% 133
2020
Q4 		$666K Buy
1,429
+74
+5% +$34.7K 0.03% 135
2020
Q3 		$598K Buy
+1,355
New +$560K 0.03% 131

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

TOBAM's TMO Position: Q2 2026 in Review

TOBAM sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 559 shares — an estimated $275K sold.

TOBAM first reported a position in TMO in Q3 2020 and held it in 19 quarters. The position peaked at $1.15M in Q1 2023. 2,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • TOBAM reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • TOBAM sold 559 Thermo Fisher Scientific shares in Q2 2026, an estimated $275K.
  • TOBAM first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 19 quarters.
  • TOBAM's Thermo Fisher Scientific position peaked at $1.15M in Q1 2023.
  • 2,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on TOBAM's 13F filing for Q2 2026, filed 31 Jul 2026.